Orlistat over the counter

British Medical Journal

Volumn 335, Issue 7631, 2007, Pages 1163-1164

  Williams, Gareth ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT; GLUCOSE; LIPID; NON PRESCRIPTION DRUG; PLACEBO; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL; VITAMIN;

BLOOD PRESSURE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DRUG INDICATION; DRUG INFORMATION; DRUG INHIBITION; DRUG SAFETY; EDITORIAL; FAT INTAKE; FECES INCONTINENCE; HEALTH BEHAVIOR; HEALTH SERVICE; HUMAN; LIFESTYLE MODIFICATION; LIPID ABSORPTION; LIPID DIET; MEDICAL SERVICE; MEDICAL SOCIETY; MEDICAL STAFF; MEDICINAL PLANT; OBESITY; PRIORITY JOURNAL; STEATORRHEA; SUSTAINED RELEASE PREPARATION; TREATMENT OUTCOME; WEIGHT REDUCTION;

ANTI-OBESITY AGENTS; DRUGS, NON-PRESCRIPTION; HUMANS; LACTONES; LIFE STYLE; OBESITY;

EID: 37249018968     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39385.347049.80     Document Type: Editorial

References (10)

1. Rucker D, Padwal R, Li SK, Curioni C, Lau DCW. Long term pharmacotherapy for obesity and overweight: updated meta-analysis. BMJ 2007;335:1194-9.
2. Pi-Sunyer FX. A review of long-term studies evaluating the efficacy of weight loss in ameliorating disorders associated with obesity. Clin Ther 1996;18:1006-35.
3. Rössner S, Sjöstrom L, Noack R, Meinders AE, Noseda G. Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. Obesity Res 2000;8:49-61.
4. Torgerson JS, Boldrin MN, Hauptman J, Sjöstrom L. Xenical in the prevention of diabetes in obese subjects (XENDOS) study. Diabetes Care 2004;27:155-61.
5. Tong PCY, Lee ZSK, Sea MM, Chow CC, Ko GT, Chan WB, et al. The effect of orlistat-induced weight-loss, without concomitant hypocatoric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes. Arch Intern Med 2002;162:2428-35.
6. Wadden TA, Berkowitz RI, Sarwer DB, Prus-Wisniewski R, Steinberg C. Benefits of lifestyle modification in the pharmacologic treatment of obesity. Arch Intern Med 2001;161:218-27.
7. Ioannides-Demos LL, Proietto I, McNeil JJ. Pharmacotherapy for obesity. Drugs 2005;65:1391-418.
8. Saul S. Hoping for a blockbuster. New York Times 2006 April 26. http://topics.nytimes.com/top/reference/timestopics/people/s/stephanie_saul/ index.html?offset=90&s=oldest.
9. WHO. Obesity, preventing and managing the global epidemic. Report of a WHO consultation. WHO Technical Report Series, 894. Geneva: WHO, 2000.
10. WHO. Diet, nutrition and the prevention of chronic disease. WHO Technical Report Series, 916. 2003. http://whqlibdoc.who.int/trs/WHO_TRS_916. pdf.